Eagle Pharmaceuticals, Inc. acquisition of stock of Arsia Therapeutics, Inc. | Practical Law
Eagle Pharmaceuticals, Inc. acquisition of stock of Arsia Therapeutics, Inc.
Enter to open, tab to navigate, enter to select
US Home
Global Home
NEW
Sign in
Sign in
All content
Search:
Search Westlaw
Search Tips
Advanced
Eagle Pharmaceuticals, Inc. acquisition of stock of Arsia Therapeutics, Inc.
Eagle Pharmaceuticals, Inc. acquisition of stock of Arsia Therapeutics, Inc.
November 10, 2016
•
Private Acquisition Agreements
•
$30 million (subject to purchase price adjustment and additional earn-out payment).
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.
Back to top